Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)
Elise A. Olsen(Durham Technical Community College), Sean Whittaker(Guy's Hospital), Nicola Pimpinelli(University of Florence), Youn Kim(Stanford University), Madeleine Duvic(Cancer Clinic), Eric C. Vonderheid(Ashford and St Peter's Hospitals NHS Foundation Trust), Robert Knobler(Medical University of Vienna), L. Laroche(Centre Hospitalier de Luxembourg), Teresa Estrach(Hospital Clínic de Barcelona), Günter Burg(Center for Pediatric Endocrinology Zurich), Rein Willemze(Leiden University Medical Center), Annamari Ranki(University of Helsinki), Franz Trautinger, Mark R. Pittelkow(Mayo Clinic in Arizona), Peter Heald(Yale University), Reinhard Dummer(University Hospital of Zurich), Gary S. Wood(University of Wisconsin–Madison), M.G. Bernengo(Department of Medical Sciences)
Cited by 1,412
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Adjuvant Dabrafenib plus Trametinib in Stage III<i>BRAF</i>-Mutated Melanoma
|New England Journal of Medicine|2017|1.5k
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
|New England Journal of Medicine|2017|1.4k
Treatment of Cutaneous T-Cell Lymphoma by Extracorporeal Photochemotherapy
|New England Journal of Medicine|1987|1.2k